These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6767466)

  • 21. Iontophoretic treatment of experimental pseudomonas keratitis in rabbit eyes using gentamicin-loaded hydrogels.
    Frucht-Pery J; Raiskup F; Mechoulam H; Shapiro M; Eljarrat-Binstock E; Domb A
    Cornea; 2006 Dec; 25(10):1182-6. PubMed ID: 17172895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic therapy of experimental Pseudomonas keratitis in guinea pigs.
    Davis SD; Sarff LD; Hyndiuk RA
    Arch Ophthalmol; 1977 Sep; 95(9):1638-43. PubMed ID: 197908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topically administered corticosteroids: effect on antibiotic-treated bacterial keratitis.
    Leibowitz HM; Kupferman A
    Arch Ophthalmol; 1980 Jul; 98(7):1287-90. PubMed ID: 7396786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical antibiotic therapy of Pseudomonas aeruginosa keratitis.
    Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1979 Sep; 97(9):1699-1702. PubMed ID: 224848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of tobramycin-soaked collagen shields vs tobramycin eyedrop loading dose for sustained treatment of experimental Pseudomonas aeruginosa-induced keratitis in rabbits.
    Assil KK; Zarnegar SR; Fouraker BD; Schanzlin DJ
    Am J Ophthalmol; 1992 Apr; 113(4):418-23. PubMed ID: 1558116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial activity of ticarcillin, tobramycin and gentamicin alone and in combination against Pseudomonas aeruginosa in vitro.
    Ullmann U
    Chemotherapy; 1977; 23(5):314-23. PubMed ID: 409590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Devastating outcome after only 6 hours of contact lens wear.
    Pandya VB; Martins A; Sharma S
    Med J Aust; 2008 Oct; 189(7):410-1. PubMed ID: 18837688
    [No Abstract]   [Full Text] [Related]  

  • 29. Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis.
    McCormick C; Caballero A; Tang A; Balzli C; Song J; O'Callaghan R
    Curr Med Res Opin; 2008 Jun; 24(6):1569-75. PubMed ID: 18423106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of minimal antibiotic treatment on bacterial keratitis.
    Hodges EJ; Friedlaender MH; Lee A; Okumoto M
    Cornea; 1989 Sep; 8(3):188-90. PubMed ID: 2501067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins.
    Willcox MD
    Clin Exp Optom; 2011 Mar; 94(2):161-8. PubMed ID: 21083760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gentamicin-resistant Pseudomonas aeruginosa corneal ulcers.
    Gelender H; Rettich C
    Cornea; 1984; 3(1):21-6. PubMed ID: 6443074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tobramycin liposomes. Single subconjunctival therapy of pseudomonal keratitis.
    Assil KK; Frucht-Perry J; Ziegler E; Schanzlin DJ; Schneiderman T; Weinreb RN
    Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3216-20. PubMed ID: 1748553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Action of gentamicin, tobramycin and their combinations with prodigiozan in an experimental infection caused by Pseudomonas aeruginosa].
    Shcherbakova EG; Medvedeva MM; Rastunova GA; Sobolev VR
    Antibiotiki; 1975; 20(12):1112-5. PubMed ID: 817650
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of tobramycin on Pseudomonas keratitis.
    Smolin G; Okumoto M; Wilson FM
    Am J Ophthalmol; 1973 Oct; 76(4):555-60. PubMed ID: 4200625
    [No Abstract]   [Full Text] [Related]  

  • 36. Tobramycin iontophoresis into corneas infected with drug-resistant Pseudomonas aeruginosa.
    Hobden JA; O'Callaghan RJ; Hill JM; Reidy JJ; Rootman DS; Thompson HW
    Curr Eye Res; 1989 Nov; 8(11):1163-9. PubMed ID: 2515036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryotherapy for experimental Pseudomonas keratitis.
    Alpren TV; Hyndiuk RA; Davis SD; Sarff LD
    Arch Ophthalmol; 1979 Apr; 97(4):711-4. PubMed ID: 426689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of habekacin, a novel aminoglycoside antibiotic, on experimental corneal ulceration due to Pseudomonas aeruginosa.
    Tanaka Y
    J Antibiot (Tokyo); 1981 Jul; 34(7):892-7. PubMed ID: 7287591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis.
    Tablan OC; Reyes MP; Rintelmann WF; Lerner AM
    J Infect Dis; 1984 Feb; 149(2):257-63. PubMed ID: 6421944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.